Breaking news

Abu Dhabi’s PureHealth Expands Its Global Reach With Greek And Cypriot Hospital Takeover

by THEFUTURE.TEAM

January 28, 2025

Abu Dhabi’s state-owned PureHealth Holding PJSC is set to acquire a 60% stake in the Greek healthcare giant Hellenic Healthcare Group (HHG) in a deal valued at around $2.3 billion. This move signals a major shift in the private healthcare sector in Greece and Cyprus.

CVC Capital Partners, currently holding a 35% stake in HHG, will retain its share. At the same time, the founder of the Greek healthcare provider will maintain the remaining ownership, according to the agreement’s details.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

The deal brings together HHG’s impressive portfolio, which includes some of Greece’s most renowned hospitals—Metropolitan, Hygeia, Metropolitan General, and Mitera—alongside key medical facilities in Cyprus, such as Apollonion Private Hospital, Aretaeio, and American Medical Center.

With this acquisition, PureHealth aims to drive growth by attracting more international patients and expanding its operations within Greece and Cyprus. The company has also indicated its interest in further acquisitions in the future.

PureHealth, with a market capitalization of around $11 billion, operates more than 100 hospitals and 300 clinics worldwide, employing over 56,000 staff. Recently, the company expanded its footprint by acquiring Circle Health Group, the UK’s largest private hospital network.

This acquisition aligns with PureHealth’s long-term strategy to generate half of its revenue from outside the Gulf Cooperation Council (GCC) countries. It also supports Abu Dhabi’s broader goals of diversifying its economy beyond oil and expanding its global healthcare presence.

HHG, established in 2018, currently operates 1,630 hospital beds across its network, serving over 1.3 million patients annually. With a workforce of more than 5,359 employees, the group also works with 6,662 doctors. In addition to its hospitals, HHG owns diagnostic centers such as HealthSpot and Platon Diagnosis, along with offering home healthcare services and medical equipment trading.

CVC first entered the Greek healthcare sector in 2017 by acquiring a majority stake in Metropolitan Hospital and has since expanded its portfolio with acquisitions of Iaso General Clinic and the Hygeia Group.

The Future Forbes Realty Global Properties

Elevating Infant Nutrition: Nara Organics Unveils Premium Organic Formula

by THEFUTURE.TEAM

July 30, 2025

The Origins Of A Vision

When Esther Hallam welcomed her daughter Nara into the world, she immediately confronted a formidable challenge: identifying a trustworthy, high-quality organic infant formula. In a U.S. market dominated by cost-cutting practices—such as the use of skim milk supplemented with oils to meet nutritional standards—Hallam observed a disconnect between established availability and uncompromised quality. Research linking corn syrup to obesity and palm oil to reduced calcium absorption only reinforced her resolve to seek a safer alternative.

Redefining Industry Standards

Frustrated by the limitations of existing options, Hallam devoted seven years to developing an organic, whole-milk formula with the expertise of leading scientists and pediatric nutritionists. Nara Organics distinguishes itself by offering the highest percentage of milk fat of any formula on the U.S. market and a significantly reduced reliance on plant-based oils. The carefully selected blend of organic sunflower, coconut, and rapeseed oils not only meets nutritional needs but also minimizes potential health risks inherent to additives like palm oil, soy, and corn syrup.

Follow THE FUTURE on LinkedIn, Facebook, Instagram, X and Telegram

Manufacturing Excellence In Germany

Rather than manufacturing domestically—a decision influenced by previous concerns over Cronobacter contamination in American facilities—Nara Organics leverages the advanced, oxygen-controlled production environment of a German facility, widely regarded as the birthplace of powdered infant formula. Chief Marketing Officer Meika Hollender detailed that their unique manufacturing process, which minimizes oxygen exposure during can sealing, substantially extends shelf life and preserves formula integrity, setting a new standard in infant nutrition.

Strategic Investment And Market Impact

Backed by $32 million from prominent investors including AlleyCorp, BBG Ventures, Corazon Ventures, Gingerbread Capital, and Torch Capital, Nara Organics has also garnered support from high-profile celebrity investors such as Serena Williams, Gina Rodriguez, and Nicky Hilton. This robust investment positions the company at the vanguard of an organic infant formula market projected to grow from $20.7 billion in 2023 to $37 billion by 2032.

Enhancing Consumer Accessibility And Community Commitment

Nara Organics is available for purchase directly via its website, subscription models, and a dedicated mobile app that assists parents in tracking essential aspects of infant care. To underscore its commitment to community well-being, the company is donating over 1,400 cans of formula to the Good+ Foundation, which strives to alleviate multi-generational poverty by providing essential services to under-resourced families.

By merging state-of-the-art production with a commitment to organic, high-quality ingredients, Nara Organics is poised to redefine the benchmarks of infant nutrition in a competitive, evolving market.